Question 1

What is Elpida Therapeutics?

Accepted Answer

Elpida Therapeutics is a Entity.

Question 2

How often does Elpida Therapeutics appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Elpida Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on May 27, 2026.

Question 4

When was Elpida Therapeutics last mentioned in news?

Accepted Answer

Last active on May 27, 2026.

Question 5

What is Elpida Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Elpida Therapeutics in global news coverage?

Accepted Answer

Attention score of 3, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Elpida Therapeutics?

Accepted Answer

LifeArc, Elpida Therapeutics Partner on Gene Therapies (May 27, 2026, 6 articles).

Question 8

How did the "LifeArc, Elpida Therapeutics Partner on Gene Therapies" event impact Elpida Therapeutics?

Accepted Answer

Elpida Therapeutics, founded by Terry and Georgia Pirovolakis, is receiving support from LifeArc to advance its gene therapy programs for SPG50, CLN7 Batten disease, and CMT4J, aiming for FDA approval by early 2028.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.